Testosterone Gel in Poor Responders Undergoing IVF
Status:
Withdrawn
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare the number of oocytes retrieved after using
transdermal testosterone gel 10 mg per day or Dehydroepiandrosterone (DHEA) 75mg per day for
6-8 weeks as pre-treatment for poor ovarian responders undergoing in-vitro fertilization
(IVF).